Australia's Therapeutic Goods Administration approves Octapharma’s human cell line recombinant FVIII Nuwiq®

Lachen, Switzerland, November 7th, 2014: Octapharma is pleased to announce that Australia's Therapeu...

Health Canada approves Octapharma’s new generation recombinant FVIII (Nuwiq®) for all age groups in haemophilia A

Lachen, Switzerland, November 5th, 2014: Octapharma Canada announces that Health Canada has approved...

Meet us globally

Since its establishment over 30 years ago, Octapharma has grown into a truly global company providing life enhancing therapies to patients in over 100 countries. To find your local Octapharma office, access our global locations map 


Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities